poisar

Stocks · News reference

Senseonics Partners With Beta Bionics To Integrate Its Eversense 365 CGM With Beta Bionics’ iLet Bionic Pancreas Automated Insulin Delivery System

BenzingaBenzinga Newsdesk

The companies are collaborating to integrate Eversense® 365 CGM with Beta Bionics’ iLet® Bionic Pancreas automated insulin delivery (AID) system designed to simplify diabetes management. The integrated device will aim

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNot Specified

    Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

    Beta Bionics (Nasdaq: BBNX) announced a public offering of 7.65 million shares at $17.25 per share, along with pre-funded warrants, expected to raise $150 million in gross proceeds. The company plans to use the funds for commercialization of its Mint patch pump, manufacturing expansion, R&D, and clinical development. The offering is expected to close on September 17, 2026.

  2. BenzingaAvi Kapoor

    Jim Cramer Says Buy Carpenter Technology, Calls This IT Services Stock a 'Value Trap'

    Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a value trap. Senseonics Holdings (NASDAQ: SENS) posts upbeat sales and Ubiquiti (NYSE: UI) reports worse-than-expected results. Hess Midstream (NYSE: HESM) is a winner while Zeta Global (NYSE: ZETA) announces a new CMO. UL Solutions (NYSE: ULS) is a potential buy and Coupang (NYSE: CPNG) is not recommended, but MercadoLibre (NASDAQ: MELI) and Amazon (NASDAQ: AMZN) are worth considering.